Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

FDA Approves Harvoni for Hepatitis C

FDA Approves Harvoni for Hepatitis C

, by Liz Highleyman

A highly effective hepatitis C drug provides a cure for many patients, but is it too expensive? Read More

Prep Use Up in SF, Advocates Seek Wider Access

Prep Use Up in SF, Advocates Seek Wider Access

, by Liz Highleyman

San Francisco rallies in support of supervisor David Campos’s resolution calling for easier access to PrEP. Read the latest on the public hearing, community meeting, and rally held this week. Read More

The Latest Infectious Disease Research: News from ICAAC 2014

The Latest Infectious Disease Research: News from ICAAC 2014

, by Liz Highleyman

An overview of key research - from new HIV medications to prevention and PrEP advances - presented at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy. Read More

AHF PrEP Ad Controversy: What Do the Numbers Mean?

AHF PrEP Ad Controversy: What Do the Numbers Mean?

, by Liz Highleyman

A new campaign from the AIDS Healthcare Foundation has sparked controversy about HIV pre-exposure prophylaxis (PrEP). Read more about the campaign, the response from PrEP endorsers, and how to evaluate PrEP efficacy study data here. Read More

HIV Prevention Tops the News at AIDS 2014

HIV Prevention Tops the News at AIDS 2014

, by Liz Highleyman

Does PrEP need to be taken daily? What else is new in HIV prevention science—and what’s the community pulse? Get the HIV prevention highlights from AIDS 2014. Read More